Sweekar - Multi-level Intersectional Stigma Reduction Intervention to Increase HIV Testing and Care Engagement in Nepal
Overview
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 31
- Locations
- 1
- Primary Endpoint
- HIV testing Self-testing kits
Overview
Brief Summary
This intervention focuses on increasing HIV testing, HIV medication adherence and reducing intersectional stigma. Our Sweekar intervention will implement 5 months of group-based activities to address the social stigma and HIV prevention and care needs.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Other
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •aged 18 years old or older
- •identify as transgender, hijra, Meti, third gender or anything other than a gender typically associated with a male assigned sex at birth
- •live in the Terai highway district Madesh Province
- •Maithili- or Nepali-speaking
- •Willing to be part of the study for 6 months
- •Willing to travel, if needed, to participate in group sessions
- •For those who test HIV negative:
- •Willing to self-test
- •Have or willing to have a mobile phone
- •Not HIV tested within the last 3 months
Exclusion Criteria
- •Cannot or will not consent to the research,
- •Female sex assigned at birth,
- •Self-identify as a man
- •Do not speak Maithli or Nepali
- •Age under 18 -
Arms & Interventions
Group-based intervention
Group-based activities and HIV self-testing to address social stigma and HIV prevention and care needs
Intervention: Sweekar intervention (Behavioral)
Outcomes
Primary Outcomes
HIV testing Self-testing kits
Time Frame: At baseline and at 3 months
Number of HIV self tests kits used at home or at a hospital or clinic
HIV testing frequency
Time Frame: Baseline, 3 months and 6 months
HIV testing; Number of times received HIV testing using clinic or resources that is not HIV self-testing kits
HIV treatment engagement
Time Frame: At baseline, 3 months and 6 months
Self-reported Wilson's Medication Scale to assess adherence patterns.
Secondary Outcomes
No secondary outcomes reported